Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonmyeloablative stem cell transplants.

C Craddock1

  • 1Department of Hematology, Hammersmith Hospital, London, UK. craddock@rpms.ac.uk

Current Opinion in Hematology
|November 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dying whilst on probation: a scoping review of mortality amongst those under community justice supervision.

Perspectives in public health·2024
Same author

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study.

Bone marrow transplantation·2023
Same author

Quantifying cardiovascular disease risk and heart age predictions for men in the prison environment.

Public health·2023
Same author

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.

Bone marrow transplantation·2020
Same author

What features of a nutrition resource are important to adolescents of a low socioeconomic status?

Public health nutrition·2020
Same author

A Comparison of Inpatient and Outpatient-Based Chemotherapy Regimens for the Treatment of Acute Myeloid Leukaemia In The Elderly.

The Ulster medical journal·2019
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Nonmyeloablative allogeneic stem cell transplantation (SCT) reduces toxicity by using less intensive conditioning. This approach aims to achieve durable donor stem cell engraftment and leverage the graft-versus-tumor effect for leukemia treatment.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Allogeneic stem cell transplantation (SCT) offers curative potential for hematologic malignancies.
  • High toxicity of traditional myeloablative conditioning regimens limits SCT efficacy.
  • Graft-versus-leukemia effect is crucial for the anti-leukemic activity of allografts.

Purpose of the Study:

  • To evaluate the efficacy and safety of nonmyeloablative conditioning protocols in allogeneic SCT.
  • To explore the potential of graft-versus-tumor effects in a less toxic transplant setting.
  • To determine if reduced-intensity conditioning can achieve durable donor stem cell engraftment.

Main Methods:

  • Development and application of minimally myelotoxic conditioning regimens.
  • Clinical protocols utilizing nonmyeloablative conditioning for allogeneic SCT.

Related Experiment Videos

  • Monitoring of donor stem cell engraftment and patient outcomes.

    • Main Results:

    • Durable engraftment of allogeneic stem cells was achieved with nonmyeloablative protocols.
    • Significant reduction in the immediate toxicity associated with transplantation was observed.
    • The anti-leukemic efficacy of this approach is under ongoing investigation.

    Conclusions:

    • Nonmyeloablative conditioning represents a less toxic alternative to myeloablative regimens for allogeneic SCT.
    • This strategy holds promise for improving the applicability and outcomes of SCT in hematologic malignancies.
    • Further research is needed to fully elucidate the long-term anti-leukemic effects.